Europe Orthopedic Biomaterials Market: Product Penetration to Drive Growth

Date: April 1, 2009
Pages: 42
Price:
US$ 3,500.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: E6BE9D3EC9CEN
Leaflet:

Download PDF Leaflet

Europe Orthopedic Biomaterials Market: Product Penetration to Drive Growth
GlobalData’s “Europe Orthopedic Biomaterials Market: Market Assessment, Insight and Forecasts to 2015” report is an essential source of data and analysis on the Europe orthopedic biomaterials market with complete coverage by categories. The report provides market landscape, competitive landscape and market trends information on four market categories – bone allografts, bone graft substitutes, bone growth stimulators, DBM and viscosupplementation. The report identifies the key trends shaping and driving the dynamism in the Europe orthopedic biomaterials market. The report also provides insight on the prevalent competitive landscape and on the emerging players which are expected to bring significant shift in the market standing of the existing leaders. The report also analyses the M&A landscape with special focus on the market participants that have been the most M&A active. The report also provides valuable insight on the pipeline products within the Europe orthopedic biomaterials market.

Scope

- The report provides market size data and information on four Europe orthopedic biomaterials market categories – Bone Allografts, Bone Graft Substitutes, Bone Growth Stimulators, DBM and Viscosupplementation.
- Annualized market revenues data from 2001 to 2008, forecast forward for 7 years to 2015.
- Analysis and review of the key events and milestones that will impact the future of the Europe orthopedic biomaterials market. Each trend independently researched to provide qualitative analysis of what the implications on sectors are, and how are companies responding to these trends.
- Insightful review of key industry drivers, restraints and challenges which are likely to impact the Europe orthopedic biomaterials market in the long run.
- In-depth analysis of the M&A landscape with a strong emphasis on the market players, likely to remain active in the near future.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Comprehensive analysis of the most likely developments expected to bring a shift to the market positions of the leading manufacturers.
- Key topics covered include the M&A landscape and the impact of the economic downturn on the US insulin delivery devices market.
- The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving Europe orthopedic biomaterials Market.
- Design and develop your product development, marketing and sales strategies by identifying the market categories poised for a strong growth.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- Identify key players best positioned to take advantage of the emerging market opportunities by developing insight on the prevalent and anticipated competitive landscape.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the Europe orthopedic biomaterials market in future.
- Effectively plan your M&A and partnership strategies by identifying companies with the most promising pipeline.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- What’s the next being thing in the Europe orthopedic biomaterials technology landscape? – Identify, understand and capitalize.

1 TABLE OF CONTENTS


1.1 LIST OF TABLES


1.2 LIST OF FIGURES


2 INTRODUCTION

2.1 Executive Summary
2.2 Definitions
2.3 Orthobiologics
  2.3.1 Bone Allografts
  2.3.2 Bone Graft Substitutes
  2.3.2.1 Bone Morphogentic Proteins (BMP)
  2.3.2.2 Synthetic Bone Graft Substitutes
  2.3.3 Bone Growth Stimulators
  2.3.4 Demineralized Bone Matrix (DBM)
  2.3.5 Viscosupplementation

3 EUROPE ORTHOPEDIC BIOMATERIALS MARKET: PRODUCT PENETRATION TO DRIVE GROWTH

3.1 Overview

4 MARKET OUTLOOK

4.1 Orthobiologics, Historic Revenue ($ m) Europe, 2001 - 2008
4.2 Orthobiologics, Forecast Revenue, Europe, 2008 – 2015
4.3 Orthobiologics, Europe, Trend Analysis
  4.3.1 Orthobiologics, Europe, Market Drivers
  4.3.1.1 Rising Orthopedic Disease Incidence and Prevalence
  4.3.1.2 The Ousting Of Autografts And Allografts As The Gold Standard
  4.3.1.3 An Under-Penetrated Market Leading To Availability Of A Wide Range Of Products
  4.3.1.4 Increasing Acceptance Of Bone Grafts Substitutes In Varying Applications
  4.3.1.5 Increased R&D Investments Fueling Product Innovations and Intermittently Growth
  4.3.1.6 Clinical and Cost Benefits to Create Greater Demand for Orthopedic Biomaterials
  4.3.1.7 Growing Awareness Leads to Advances in Biomaterials
  4.3.2 Orthobiologics, Europe, Market Restraints
4.4 Orthobiologics, Cross Segment Analysis, Europe, 2008
4.5 Orthobiologics, Cross Country Analysis, Europe
4.6 Orthobiologics, Europe, Competitive Landscape
4.7 Orthobiologics, Europe, M&A Landscape
4.8 Top Deals Of The year
  4.8.1 BoneSupport Acquires Ultrazonix
  4.8.2 NuVasive To Invest In Progentix Orthobiology
  4.8.3 aap Implantate Completes Private Placement Of $1.68 Million

5 ORTHOBIOLOGICS, SEGMENT ANALYSIS

5.1 Bone Allografts
  5.1.1 Overview
  5.1.2 Bone Allografts, Market Analysis, Europe
  5.1.3 Bone Allografts, Market Trend Analysis
  5.1.3.1 Bone Allografts, Market Drivers
Bone Allografts, Market Restraints
5.2 Bone Graft Substitutes
  5.2.1 Overview
  5.2.2 Bone Grafts Substitutes, Market Analysis, Europe
  5.2.3 Bone Grafts Substitutes, Market Trend Analysis
  5.2.3.1 Bone Graft Substitutes, Market Drivers
  5.2.3.2 Bone Graft Substitutes, Market Restraints
5.3 Bone Growth Stimulators
  5.3.1 Overview
  5.3.2 Bone Growth Stimulators, Market Analysis, Europe
  5.3.3 Bone Growth Stimulators, Market Trend Analysis
  5.3.3.1 Bone Growth Stimulators, Market Drivers
  5.3.3.2 Bone Growth Stimulators, Market Restraints
5.4 Demineralized Bone Matrix (DBM)
  5.4.1 Overview
  5.4.2 Demineralized Bone Matrix, Market Analysis, Europe
  5.4.3 Demineralized Bone Matrix, Market Trend, Analysis
  5.4.3.1 Demineralized Bone Matrix, Market Drivers
5.5 Viscosupplementation
  5.5.1 Overview
  5.5.2 Viscosupplementation, Market Analysis, Europe
  5.5.3 Viscosupplementation, Market Trend Analysis
  5.5.3.1 Viscosupplementation, Market Drivers
  5.5.3.2 Viscosupplementation, Market Restraints

6 FUTURE OUTLOOK


7 APPENDIX

7.1 Methodology
  7.1.1 Coverage
  7.1.2 Secondary Research
  7.1.3 Primary Research
  7.1.4 Models
  7.1.5 Forecasts
  7.1.6 Expert Panel Validation
7.2 Contact US
7.3 Disclaimer

1.1 LIST OF TABLES

Table 1: Orthobiologics, Historic Revenue ($ m), Europe, 2001 - 2008
Table 2: Orthobiologics, Forecast Revenue, Europe, 2008 - 2015
Table 3: Orthobiologics, Cross Segment Analysis, Historic Vs Forecasted CAGR, 2008
Table 4: Orthobiologics, Cross Country Analysis, Historic Vs Forecasted CAGR, 2008
Table 5: Orthobiologics, Deal Value And Volume, Europe, 2004 - 2008
Table 6: Bone Allografts, Revenue ($ m), Europe, 2001 – 2015
Table 7: Bone Graft Substitutes, Revenue ($ m), Europe, 2001 – 2015
Table 8: Bone Growth Stimulators, Revenue ($ m), Europe, 2001 – 2015
Table 9: Demineralized Bone Matrix, Revenue ($ m), Europe, 2001 – 2015
Table 10: Viscosupplementation, Revenue ($ m), Europe, 2001 – 2015

1.2 LIST OF FIGURES

Figure 1: Orthobiologics, Percentage Contribution of Revenue, Global, 2008
Figure 2: Orthobiologics, Historic Revenue ($ m), Europe, 2001 - 2008
Figure 3: Orthobiologics, Forecast Revenue, Europe, 2008 - 2015
Figure 4: Orthobiologics, Cross Segment Analysis, Historic Vs Forecasted CAGR, 2008
Figure 5: Orthobiologics, Cross Country Analysis, Historic Vs Forecasted CAGR, 2008
Figure 6: Orthobiologics, Company Share (%), Europe, 2008
Figure 7: Orthobiologics, Deal Value And Volume, Europe, 2004 - 2008
Figure 8: Bone Allografts, Revenue ($ m), Europe, 2001 – 2015
Figure 9: Bone Graft Substitutes, Revenue ($ m), Europe, 2001 – 2015
Figure 10: Bone Growth Stimulators, Revenue ($ m), Europe, 2001 – 2015
Figure 11: Demineralized Bone Matrix, Revenue ($ m), Europe, 2001 – 2015
Figure 12: Viscosupplementation, Revenue ($ m), Europe, 2001 – 2015
Figure 13: GlobalData Methodology
Orthopedic Biomaterials, The World Market US$ 3,995.00 May, 2011 · 250 pages
U.S. Market for Orthopedic Biomaterials US$ 5,946.00 Sep, 2013 · 273 pages

Ask Your Question

Europe Orthopedic Biomaterials Market: Product Penetration to Drive Growth
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: